Measles Vaccination with Reduced DosageBr Med J 1968; 4 doi: https://doi.org/10.1136/bmj.4.5622.28 (Published 05 October 1968) Cite this as: Br Med J 1968;4:28
- R. G. Hendrickse,
- D. Montefiore
A field trial is reported in which good sero-conversion rates were obtained when a dose of 200 TCID50 Beckenham 31 strain (Wellcovax) measles vaccine was administered by Ped-O-Jet subcutaneously in a volume of 0.5 ml. per dose. It is suggested that use of this reduced dosage would lead to a significant reduction in the cost per dose of the vaccine, especially when administered on a scale large enough to justify the use of multidose containers.